Analysis of adverse events following the treatment of autologous cytokine-induced killer cells for adoptive immunotherapy in malignant tumour sufferers

Phase I clinical trial of human vascular endothelial growth factor receptor 1 peptide vaccines for patients with metastatic renal cell carcinoma

(2013) K Yoshimura et al.   BRITISH JOURNAL OF CANCER

Autologous CIK Cell Immunotherapy in Patients with Renal Cell Carcinoma after Radical Nephrectomy

(2013) Yajing Zhang et al.   Clinical & Developmental Immunology

A Phase I Study of an Agonist CD40 Monoclonal Antibody (CP-870,893) in Combination with Gemcitabine in Patients with Advanced Pancreatic Ductal Adenocarcinoma

(2013) G. L. Beatty et al.   CLINICAL CANCER RESEARCH

Cytokine-induced killer cells promote antitumor immunity

(2013) Jingting Jiang et al.   Journal of Translational Medicine

Efficacy of adjuvant immunotherapy with cytokine-induced killer cells in patients with locally advanced gastric cancer

(2012) Liangrong Shi et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Clinical Studies Applying Cytokine-Induced Killer Cells for the Treatment of Renal Cell Carcinoma

(2012) Clara E. Jäkel et al.   Clinical & Developmental Immunology

Randomized Study of Autologous Cytokine-Induced Killer Cell Immunotherapy in Metastatic Renal Carcinoma

(2012) L. Liu et al.   CLINICAL CANCER RESEARCH

Adoptive immunotherapy with cytokine-induced killer cells generated with a new good manufacturing practice-grade protocol

(2012) Sergio Rutella et al.   CYTOTHERAPY

CIK cells from recurrent or refractory AML patients can be efficiently expanded in vitro and used for reduction of leukemic blasts in vivo

(2012) Yao Wang et al.   EXPERIMENTAL HEMATOLOGY

Adoptive Immunotherapy with Cytokine-Induced Killer Cells for Patients with Relapsed Hematologic Malignancies after Allogeneic Hematopoietic Cell Transplantation

(2011) Ginna G. Laport et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Adverse events following infusion of T cells for adoptive immunotherapy: a 10-year experience

(2010) Conrad Russell Cruz et al.   CYTOTHERAPY

Clinical trials on CIK cells: first report of the international registry on CIK cells (IRCC)

(2010) C. Hontscha et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Integrated data from 2 randomized, double-blind, placebo-controlled, phase 3 trials of active cellular immunotherapy with sipuleucel-T in advanced prostate cancer

(2009) Celestia S. Higano et al.   CANCER

Integrating the biological characteristics of oncolytic viruses and immune cells can optimize therapeutic benefits of cell-based delivery

(2008) S H Thorne et al.   GENE THERAPY

Monoclonal Antibody First Dose Cytokine Release Syndromes–Mechanisms and Prediction

(2008) Mark Wing   Journal of Immunotoxicology